Social adversity and regional differences in prescribing of ADHD medication for school-age children

Journal of Developmental and Behavioral Pediatrics

Volumn 36, Issue 5, 2015, Pages 330-341

  Wallach Kildemoes, Helle ^a   Skovgaard, Anne M ^a   Thielen, Karsten ^a   Pottegård, Anton ^b   Mortensen, Laust H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

ADHD medication; children; prescribing practice variation; regional variation; social adversity

Indexed keywords

CENTRAL STIMULANT AGENT;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CLINICAL PRACTICE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DENMARK; DRUG UTILIZATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PSYCHOLOGY; RISK FACTOR; SINGLE PARENT; SOCIAL ASPECTS AND RELATED PHENOMENA; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; DRUG UTILIZATION; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; PRACTICE PATTERNS, PHYSICIANS'; RISK FACTORS; SINGLE PARENT; SOCIOLOGICAL FACTORS;

EID: 84930891851     PISSN: 0196206X     EISSN: 15367312     Source Type: Journal    
DOI: 10.1097/DBP.0000000000000170     Document Type: Article

References (40)

1. Reddy DS. Current pharmacotherapy of attention deficit hyperactivity disorder. Drugs Today (Barc). 2013;49:647-665.
2. Isaacs D. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (For). J Paediatr Child Health. 2006;42:544-547.
3. Frances AJ, Widiger T. Psychiatric diagnosis: lessons from the DSMIV past and cautions for the DSM-5 future. Annu Rev Clin Psychol. 2012;8:109-130.
4. Kendall T, Taylor E, Perez A, et al. Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. BMJ. 2008;337:a1239.
5. Singh I. A disorder of anger and aggression: children's perspectives on attention deficit/hyperactivity disorder in the UK. Soc Sci Med. 2011;73:889-896.
6. Graham LJ. From ABCs to ADHD: the role of schooling in the construction of behaviour disorder and production of disorderly objects. Int J Inclusive Educ. 2008;12:7-33.
7. Russell G, Ford T, Rosenberg R, et al. The association of attention deficit hyperactivity disorder with socioeconomic disadvantage: alternative explanations and evidence. J Child Psychol Psychiatry. 2014;55:436-445.
8. Duric NS, Elgen I. Characteristics of Norwegian children suffering from ADHD symptoms: ADHD and primary health care. Psychiatry Res. 2011;188:402-405.
9. Elberling H, Linneberg A, Olsen EM, et al. Infancy predictors of hyperkinetic and pervasive developmental disorders at ages 5-7 years: results from the Copenhagen Child Cohort CCC2000. J Child Psychol Psychiatry. 2014;55:1328-1335.
10. Hinshaw SP, Scheffler RM, Fulton BD, et al. International variation in treatment procedures for ADHD: social context and recent trends. Psychiatr Serv. 2011;62:459-464.
11. Pottegard A, Bjerregaard BK, Glintborg D, et al. The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective. Eur J Clin Pharmacol. 2012;68:1443-1450.
12. Zoega H, Furu K, Halldorsson M, et al. Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand. 2011;123:360-367.
13. Paris J. The Use and Misuse of Psyhiatric Drugs. An Evidence-Based Critique. 1st ed. West Sussex, United Kingdom: John Wiley & Sons, Ltd; 2010.
14. Hjern A, Weitoft GR, Lindblad F. Social adversity predicts ADHDmedication in school children-a national cohort study. Acta Paediatr. 2010;99:920-924.
15. Galera C, Pingault JB, Michel G, et al. Clinical and social factors associated with attention-deficit hyperactivity disorder medication use: population-based longitudinal study. Br J Psychiatry. 2014; 205:291-297.
16. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366:237-248.
17. Sonuga-Barke EJ, Halperin JM. Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention? J Child Psychol Psychiatry. 2010;51:368-389.
18. Thapar A, Cooper M, Eyre O, et al. What have we learnt about the causes of ADHD? J Child Psychol Psychiatry. 2013;54:3-16.
19. Garland AF, Brookman-Frazee L, Gray E. The role of parent characteristics in community-based medication treatment for children with disruptive behavior problems. Community Ment Health J. 2013;49:507-514.
20. Thygesen LC, Daasnes C, Thaulow I, et al. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation and archiving. Scand J Public Health. 2011;39(suppl 7): 12-16.
21. Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(suppl 7):38-41.
22. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC Classification and DDD Assignment, 2014. Oslo, Norway: Norwegian Institute of Public Health; 2014.
23. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(suppl 7):30-33.
24. ICD-10 Classification of Mental and Behavioural Disorders. Geneva, Switzerland: World Health Organisation; 2014. Available at: http://www.who.int/substance-abuse/terminology/icd-10/en/. Accessed June 1, 2014.
25. Guide to Medicamental Treatment of Children and Adolescents with Psychiatric Disorders: Danish National Board of Health; 2010. Available at: https://www.retsinformation.dk/print.aspx?id5114817&exp51. Accessed February 1, 2015.
26. Rowland AS, Skipper BJ, Umbach DM, et al. The prevalence of ADHD in a population-based sample. J Atten Disord. [published online ahead of print December 11, 2013]. doi: 10.1177/1087054713513799.
27. Kovshoff H, Williams S, Vrijens M, et al. The decisions regarding ADHD management (DRAMa) study: uncertainties and complexities in assessment, diagnosis and treatment, from the clinician's point of view. Eur Child Adolesc Psychiatry. 2012;21:87-99.
28. Kitagawa EM. Components of a difference between 2 rates. J Am Stat Assoc. 1955;50:1168-1194.
29. Wagstaff A, van Doorslaer E, Watanabe N. On decomposing the causes of health sector inequalities with an application to malnutrition inequalities in Vietnam. J Econom. 2003;112:207-223.
30. Thomsen PH, Rasmussen H, Isager T. Reference program for børn og unge med ADHD. Copenhagen, Denmark: Børne-og Ungdomspsykiatrisk Selskab i Danmark; 2008.
31. Froehlich TE, Lanphear BP, Epstein JN, et al. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161:857-864.
32. Reyes N, Baumgardner DJ, Simmons DH, et al. The potential for sociocultural factors in the diagnosis of ADHD in children. WMJ. 2013;112:13-17.
33. Rowland AS, Umbach DM, Stallone L, et al. Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. Am J Public Health. 2002;92:231-234.
34. Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry. 1997;36: 1036-1045.
35. Zwirs BW, Burger H, Buitelaar JK, et al. Ethnic differences in parental detection of externalizing disorders. Eur Child Adolesc Psychiatry. 2006;15:418-426.
36. Pham AV, Carlson JS, Kosciulek JF. Ethnic differences in parental beliefs of attention-deficit/hyperactivity disorder and treatment. J Atten Disord. 2010;13:584-591.
37. Wrigth GS. The Medicalization Trap. A Study of the Labeling of Children as ADHD. Sydney, Australia: Bookpal; 2013.
38. Schneider H, Eisenberg D. Who receives a diagnosis of attentiondeficit/hyperactivity disorder in the United States elementary school population? Pediatrics. 2006;117:e601-e609.
39. Rousseau C, Measham T, Bathiche-Suidan M. DSM IV, culture and child psychiatry. J Can Acad Child Adolesc Psychiatry. 2008;17: 69-75.
40. Moncrieff J, Timimi S. The social and cultural construction of psychiatric knowledge: an analysis of NICE guidelines on depression and ADHD. Anthropol Med. 2013;20:59-71.